Various copper and iron overload patterns in the livers of patients with Wilson disease and idiopathic copper toxicosis

Medical Molecular Morphology

Volumn 46, Issue 3, 2013, Pages 133-140

  Hayashi, Hisao ^a   Hattori, Ai ^a,b   Tatsumi, Yasuaki ^a   Hayashi, Kazuhiko ^b   Katano, Yoshiaki ^b   Ueyama, Jun ^b   Wakusawa, Shinya ^b   Yano, Motoyoshi ^c   Goto, Hidemi ^b  

^a AICHI GAKUIN UNIVERSITY   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c Yokkaichi Municipal Hospital   (Japan)

Author keywords

Copper; Idiopathic copper toxicosis; Iron; Liver; Wilson disease; X ray microanalysis

Indexed keywords

CERULOPLASMIN; COPPER; IRON;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; COPPER OVERLOAD; DISEASE ASSOCIATION; ELECTRON MICROSCOPE; FEMALE; HUMAN; HUMAN TISSUE; HYPOCERULOPLASMINEMIA; IDIOPATHIC COPPER TOXICOSIS; IRON METABOLISM; IRON OVERLOAD; LIVER BIOPSY; MALE; METABOLIC DISORDER; PRIORITY JOURNAL; WILSON DISEASE;

ADOLESCENT; ADULT; CHILD; COPPER; FEMALE; HEPATOLENTICULAR DEGENERATION; HUMANS; IRON OVERLOAD; LIVER; LIVER CIRRHOSIS; MALE; METAL METABOLISM, INBORN ERRORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84884590292     PISSN: 18601480     EISSN: 18601499     Source Type: Journal    
DOI: 10.1007/s00795-013-0015-2     Document Type: Article

References (26)

1. Gitlin JD (2003) Wilson disease. Gastroenterology 125:1868-1877
2. Yamaguchi Y, Heiny ME, Gitlin JD (1993) Isolation and characterization of a human liver cDNA as a candidate gene for Wilson disease. Biochem Biophys Res Commun 197:271-277
3. Scheinberg IH, Sternlieb I (1994) Is non-Indian childhood cirrhosis caused by dietary copper? Lancet 344:1002-1004
4. Tanner MS, Portmann B, Mowat AP, Williams R, Pandit AN, Mills GF (1979) Increased hepatic copper concentration in Indian childhood cirrhosis. Lancet 1:1203-1205
5. Muller T, Feichtinger H, Berger H, Muller W (1996) Endemic Tyrolean infantile cirrhosis: an ecogenetic disorder. Lancet 347:877
6. Hanaichi T, Kidokoro R, Hayashi H, Sakamoto N (1984) Electron probe X-ray analysis on human hepatocellular lysosomes with copper deposits: copper binding to a thiol-protein in lysosomes. Lab Invest 51:592-597
7. Shiono Y, Wakusawa S, Hayashi H, Takikawa T, Yano M, Okada T, Mabuchi H, Kono S, Miyajima H (2001) Iron accumulation in the liver of male patients with Wilson's disease. Am J Gastroenterol 96:3147-3151
8. Pietrangelo A (2007) Hemochromatosis: an endocrine liver disease. Hepatology 46:1291-1301
9. Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, Ward DM, Ganz T, Kaplan J (2004) Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306:2090-2093
10. Bridle KR, Frazer DM, Wilkins SJ, Dixon JL, Purdie DM, Crawford DH, Subramaniam VN, Powell LW, Anderson GL, Ramm GA (2003) Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis. Lancet 361:669-673
11. Motonishi S, Hayashi H, Fujita Y, Okada T, Kusakabe A (2006) Copper- and iron-rich matrices in hepatocellular lipofuscin particles of a young male patient: diagnostic ultrastructures for Wilson disease. Ultrastruct Pathol 30:409-414
12. Hayashi H, Yano M, Fujita Y, Wakusawa S (2006) Compound overload of copper and iron in patients with Wilson's disease. Med Mol Morphol 39:121-126
13. Hayashi H, Fujita Y, Tatsumi Y, Hattori A, Hayashi K, Katano Y, Wakusawa S, Yano M, Itoh M, Mizutani N, Goto H (2009) Special stain and X-ray probe microanalysis of livers with Wilson disease. Hepatol Res 39:563-568
14. Tatsumi Y, Shinohara T, Imoto M, Wakusawa S, Yano M, Hayashi K, Hattori A, Hayashi H, Shimizu A, Ichiki T, Nakashima S, Katano Y, Goto H (2011) Potential of the international scoring system for the diagnosis of Wilson disease to differentiate Japanese patients who need anti-copper treatment. Hepatol Res 41:887-896
15. Ferenci P, Caca K, Loudianos G, Mieli-Vergani G, Tanner S, Sternlieb I, Schilsky M, Cox D, Berr F (2003) Diagnosis and phenotypic classification of Wilson disease. Liver Int 23:139-142
16. Walshe JM, Cox DW (1998) Effect of treatment of Wilson's disease on natural history of haemochromatosis. Lancet 352:112-113
17. Erhardt A, Hoffmann A, Hefter H, Haussinger D (2002) HFE gene mutations and iron metabolism in Wilson's diease. Liver 22:474-478
18. Merryweather-Clarke AT, Pointon JJ, Shearman JD, Robson KJ (1997) Global prevalence of putative haemochromatosis mutations. J Med Genet 34:275-278
19. Roberts EA, Schilsky ML (2003) A practice guideline on Wilson disease. Hepatology 37:1475-1492
20. Osaki S, Johnson DA, Frieden E (1971) The mobilization of iron from the perfused mammalian liver by a serum copper enzyme ferroxidase. J Biol Chem 246:3018-3023
21. Attieh ZK, Mukhopadhyay CK, Seshadri V, Tripoulas NA, Fox PL (1999) Ceruloplasmin ferroxidase activity stimulates cellular iron uptake by a trivalent cation-specific transport mechanism. J Biol Chem 274:1116-1123
22. Miyajima H, Nishimura Y, Mizoguchi K, Sakamoto M, Shimizu T, Honda N (1987) Familial apoceruloplasmin deficiency associated with blepharospasm and retinal degeneration. Neurology 37:761-767
23. Goldfischer S, Sternlieb I (1968) Changes in the distribution of hepatic copper in relation to the progression of Wilson's disease (hepatolenticular degeneration). Am J Pathol 53:883-901
24. Hayashi H, Piperno A, Tomosugi N, Hayashi K, Kimura F, Wakusawa S, Yano M, Tatsumi Y, Hattori A, Pelucchi S, Katano Y, Goto H (2010) Patients with chronic hepatitis C may be more sensitive to iron hepatotoxicity than patients with HFE-hemochromatosis. Intern Med 49:2371-2377
25. Hellman NE, Schaefer M, Gehrke S, Stegen P, Hoffman WJ, Gitlin JD, Stremmel W (2000) Hepatic iron overload in aceruloplasminemia. Gut 47:858-860
26. Mariani R, Arosio C, Pelucchi S, Grisoli M, Piga A, Trombini P, Piperno A (2004) Iron chelation therapy in aceruloplasminemia: study of a patient with a novel missense mutation. Gut 53:756-758